Quality of life in psoriasis patients

Standard

Quality of life in psoriasis patients. / Augustin, Matthias; Radtke, Marc Alexander.

in: EXPERT REV PHARM OUT, Jahrgang 14, Nr. 4, 2014, S. 559-568.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{49fe75776772487e9c037b58369207f2,
title = "Quality of life in psoriasis patients",
abstract = "Patient-reported outcomes are major components of decision making in clinical research, reimbursement, health policy and health care for psoriasis. The most important construct in patient-reported outcomes is health-related quality of life (HRQoL) which encompasses the individual's well-being with respect to health. HRQoL cannot directly be measured but is assessed in single dimensions, especially physical, emotional, social and functional aspects. For this, disease- and condition-specific instruments are used. Psoriasis is a chronic inflammatory disease affecting the skin as well as other tissues and organ systems. Patients suffer from a large scale of impairments, for example, physical symptoms, stigmatization and embarrassment, psychological strain and disabilities in profession. Improvement of HRQoL is a major objective of disease management. Current knowledge on determinants of HRQoL and the treatments available increase QoL in clinical care.",
author = "Matthias Augustin and Radtke, {Marc Alexander}",
year = "2014",
doi = "10.1586/14737167.2014.914437",
language = "English",
volume = "14",
pages = "559--568",
journal = "EXPERT REV PHARM OUT",
issn = "1473-7167",
publisher = "EXPERT REVIEWS",
number = "4",

}

RIS

TY - JOUR

T1 - Quality of life in psoriasis patients

AU - Augustin, Matthias

AU - Radtke, Marc Alexander

PY - 2014

Y1 - 2014

N2 - Patient-reported outcomes are major components of decision making in clinical research, reimbursement, health policy and health care for psoriasis. The most important construct in patient-reported outcomes is health-related quality of life (HRQoL) which encompasses the individual's well-being with respect to health. HRQoL cannot directly be measured but is assessed in single dimensions, especially physical, emotional, social and functional aspects. For this, disease- and condition-specific instruments are used. Psoriasis is a chronic inflammatory disease affecting the skin as well as other tissues and organ systems. Patients suffer from a large scale of impairments, for example, physical symptoms, stigmatization and embarrassment, psychological strain and disabilities in profession. Improvement of HRQoL is a major objective of disease management. Current knowledge on determinants of HRQoL and the treatments available increase QoL in clinical care.

AB - Patient-reported outcomes are major components of decision making in clinical research, reimbursement, health policy and health care for psoriasis. The most important construct in patient-reported outcomes is health-related quality of life (HRQoL) which encompasses the individual's well-being with respect to health. HRQoL cannot directly be measured but is assessed in single dimensions, especially physical, emotional, social and functional aspects. For this, disease- and condition-specific instruments are used. Psoriasis is a chronic inflammatory disease affecting the skin as well as other tissues and organ systems. Patients suffer from a large scale of impairments, for example, physical symptoms, stigmatization and embarrassment, psychological strain and disabilities in profession. Improvement of HRQoL is a major objective of disease management. Current knowledge on determinants of HRQoL and the treatments available increase QoL in clinical care.

U2 - 10.1586/14737167.2014.914437

DO - 10.1586/14737167.2014.914437

M3 - SCORING: Journal article

C2 - 24820452

VL - 14

SP - 559

EP - 568

JO - EXPERT REV PHARM OUT

JF - EXPERT REV PHARM OUT

SN - 1473-7167

IS - 4

ER -